FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with

Read more

Immunology: A Very British History

Britain has been home to many pioneers of immunology, ranging from cellular biologists to virologists and biochemists. This article aims

Read more